MariMed Inc. (MRMD) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts MRMD Hot Sheet
Join SI Premium – FREE
MariMed Inc. (OTC: MRMD) reported Q4 EPS of ($0.02), $0.01 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $39 million versus the consensus estimate of $42.45 million.
For earnings history and earnings-related data on MariMed Inc. (MRMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
- Agora Inc. (API) PT Raised to $6.80 at BofA Securities
- DeFi Technologies Inc. (DEFT) Reports Q2 Loss of $0.04
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
